<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04051190</url>
  </required_header>
  <id_info>
    <org_study_id>2019/252</org_study_id>
    <nct_id>NCT04051190</nct_id>
  </id_info>
  <brief_title>Effect of Diet Versus Sleeve Gastrectomy and Gastric Bypass on Appetite</brief_title>
  <acronym>DISGAP</acronym>
  <official_title>Effects of Diet-induced Weight Loss Versus Sleeve Gastrectomy and Gastric Bypass on Homeostatic and Hedonic Appetite Markers and Gut Microbiota</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Namsos Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Leeds</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian University of Life Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The biggest challenge in obesity management is maintaining weight loss in the long-term.
      Currently, bariatric surgery is the most effective treatment, leading to sustained weight
      loss that is not yet achievable with lifestyle intervention (e.g. diet). The reasons behind
      its success is still not clearly understood, but beneficial changes in the homeostatic and
      hedonic appetite systems (the two major physiological regulators of appetite), along with the
      microbiome (known to have a mediatory effect on appetite) have been shown to occur after
      bariatric surgery. These alterations are in opposition to what is seen after diet-induced
      weight loss. Today, the component of appetite regulation that drives bariatric surgeys'
      long-term success is still unknown. By comparing a lifestyle and surgical intervention in
      parallel, the investigators can observe the impact of a similar magnitude of weight loss on
      these three domains of appetite regulation simultaneously, thereby illuminating the
      mechanisms behind bariatric surgerys' success.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2, 2019</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial blood plasma concentration of Glucagon-like peptide-1 (GLP-1, satiety hormone)</measure>
    <time_frame>Week 11</time_frame>
    <description>Blood samples will be collected at fasting, and then every 30 minutes after a standardized test meal up to 150 minutes. A radioimmunoassay method will be used to measure the concentration of total GLP-1. This method measures antigen concentrations by the use of antibodies.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>VLED group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will undergo a 10-week VLED.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sleeve Gastrectomy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will undergo standard clinical practice prior to surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gatric Bypass group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will undergo standard clinical practice prior to surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>VLED group</intervention_name>
    <description>10-week weight loss period with total meal replacement, consisting of 750 kcal/day. Measurements will be taken at baseline (before diet start), 10 weeks after intervention start (Wk11), and at 1 year.</description>
    <arm_group_label>Gatric Bypass group</arm_group_label>
    <arm_group_label>Sleeve Gastrectomy group</arm_group_label>
    <arm_group_label>VLED group</arm_group_label>
    <other_name>very-low-energy-diet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sleeve Gastrectomy group</intervention_name>
    <description>Standard clinical practice with 2-week diet consisting of 750 kcal/day prior to surgery. The pre- and post-surgical diet of this group will be matched with the VLED group in macro- and micronutrient composition. Measurements will be taken at baseline (before diet start), 10 weeks after intervention start (Wk11), and 1 year after surgery (sleeve gastrectomy)</description>
    <arm_group_label>Sleeve Gastrectomy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gastric Bypass group</intervention_name>
    <description>Standard clinical practice with 2-week diet consisting of 750 kcal/day prior to surgery. The pre- and post-surgical diet of this group will be matched with the VLED group in macro- and micronutrient composition. Measurements will be taken at baseline (before diet start), 10 weeks after intervention start (Wk11), and 1 year after surgery (gastric bypass)</description>
    <arm_group_label>Gatric Bypass group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled for bariatric surgery

          -  patient in obesity clinic

          -  Body mass index (BMI) 35-55

        Exclusion Criteria:

          -  Currently taking medication known to affect energy metabolism or appetite

          -  Current cancer diagnosis

          -  Substance abuse

          -  Enrolled in another obesity treatment

          -  Eating disorders

          -  pre-existing endocrine disorders (e.g. diabetes) will not be excluded, but final
             analysis will controlled for these conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catia Martins, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marthe Isaksen Aukan</last_name>
    <phone>+4792804568</phone>
    <email>marthe.i.aukan@ntnu.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Siren Nymo, PhD</last_name>
    <phone>+4799514188</phone>
    <email>siren.nymo@ntnu.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Namsos Hospital</name>
      <address>
        <city>Namsos</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siren Nymo, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marthe Isaksen Aukan</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>August 7, 2019</study_first_submitted>
  <study_first_submitted_qc>August 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2019</study_first_posted>
  <last_update_submitted>December 29, 2019</last_update_submitted>
  <last_update_submitted_qc>December 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diet</keyword>
  <keyword>bariatric surgery</keyword>
  <keyword>appetite</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

